Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesMice, Inbred C57BLHematopoiesisCombined Modality TherapyKidney TransplantationTime FactorsRecurrenceT-LymphocytesTreatment OutcomeRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteImmunosuppressive AgentsBone Marrow ExaminationHematologic NeoplasmsRemission InductionGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidBone Marrow NeoplasmsTransplantation ImmunologyFlow CytometryLymphoma, Non-HodgkinImmunosuppressionLymphocyte DepletionAcute DiseaseGraft vs Host ReactionStem Cell TransplantationLeukocyte TransfusionCells, CulturedLeukocytes, MononuclearColony-Forming Units AssaySurvival AnalysisRetrospective StudiesHeart TransplantationLeukocyte CountHLA AntigensChimeraSevere Combined ImmunodeficiencyMyelodysplastic SyndromesCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CLymphocytesGranulocyte Colony-Stimulating FactorCyclosporineLung TransplantationHematologic DiseasesLymphocyte TransfusionPeripheral Blood Stem Cell TransplantationFollow-Up StudiesActuarial AnalysisBlood CellsSpleenSurvival RateBone DensityAntibodies, MonoclonalCarmustineAntigens, CD34LymphomaImmunophenotypingNuclear FamilyPancytopeniaDisease-Free SurvivalOrgan TransplantationGraft vs Tumor EffectCytarabineCytomegalovirus InfectionsTumor Necrosis Factor-alphaLymphocyte ActivationMelphalanPolymerase Chain ReactionMultiple MyelomaCell SeparationEtoposide